ENTOD Pharma launches India’s first ocular probiotic blend designed for healthy eyes

image credit- shutterstock

Mumbai-based ENTOD Pharmaceuticals, a global leader in eye health innovation, has announced the launch of OCUBIOME™, India’s first ocular probiotic blend designed for healthy eyes. This proprietary formulation has been exclusively developed by the company’s R&D at their Navi Mumbai research centre.

With today’s fast-paced, screen-dominated lifestyles and rising corrective eye surgeries, conditions like dry eye syndrome and ocular discomfort are becoming widespread. Millions silently struggle with burning eyes, blurred vision, and post-surgical recovery issues every day. While existing therapies such as lubricants provide only short-lived relief, there remains a need for holistic, long-term solutions. OCUBIOME™ complements the action of lubricants by restoring ocular and gut microbiota balance, thereby adding sustained benefits to immediate relief

Delivered in a convenient, mouth-melting, no-added sugar sachets, it offers a simple once-daily routine that helps supports ocular comfort, digital eye strain recovery and promotes long-term eye health.

The launch marks a turning point for preventive eye care. As awareness around the gut–eye axis grows, OCUBIOME™ opens a new avenue for proactive management of eye health, offering patients a bold step beyond symptom relief.

OCUBIOME™ will be available against the prescription of an eye doctor from November 2025.